Very Low–Calorie Diet Mimics the Early Beneficial Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity and β-Cell Function in Type 2 Diabetic Patients
Clifton Jackness,Wahida Karmally,Gerardo Febres,Irene M. Conwell,Leaque Ahmed,Marc Bessler,Donald J. McMahon,Judith Korner +7 more
Reads0
Chats0
TLDR
Insulin sensitivity, acute insulin secretion after intravenous glucose administration, and β-cell function as determined by disposition index improved to a similar extent in both groups and changes in fasting glucose and fructosamine levels were similar.Abstract:
Marked improvement in glycemic control occurs in patients with type 2 diabetes mellitus shortly after Roux-en-Y gastric bypass surgery (RYGB) and before there is major weight loss. The objective of this study was to determine whether the magnitude of this change is primarily due to caloric restriction or is unique to the surgical procedure. We studied eleven subjects who underwent RYGB and fourteen subjects mean-matched for BMI, HbA1c, and diabetes duration who were admitted to our inpatient research unit and given a very low–calorie diet (VLCD) of 500 kcal/day with a macronutrient content similar to that consumed by patients after RYGB. Frequently sampled intravenous glucose tolerance tests were performed before and after interventions. Both groups lost an equivalent amount of weight over a mean study period of 21 days. Insulin sensitivity, acute insulin secretion after intravenous glucose administration, and β-cell function as determined by disposition index improved to a similar extent in both groups. Likewise, changes in fasting glucose and fructosamine levels were similar. Based on these data, VLCD improves insulin sensitivity and β-cell function just as well as RYGB in the short term.read more
Citations
More filters
Journal ArticleDOI
FXR is a molecular target for the effects of vertical sleeve gastrectomy
Karen K. Ryan,Valentina Tremaroli,Christoffer Clemmensen,Christoffer Clemmensen,Petia Kovatcheva-Datchary,Andriy Myronovych,Rebekah Karns,Hilary E. Wilson-Pérez,Darleen A. Sandoval,Rohit Kohli,Fredrik Bäckhed,Fredrik Bäckhed,Randy J. Seeley +12 more
TL;DR: It is demonstrated that the therapeutic value of VSG does not result from mechanical restriction imposed by a smaller stomach, rather, VSG is associated with increased circulating bile acids, and associated changes to gut microbial communities, which point to bile acid and FXR signalling as an important molecular underpinning for the beneficial effects of this weight-loss surgery.
Journal ArticleDOI
Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes.
Elizabeth F. Sutton,Robbie A. Beyl,Kate S. Early,William T. Cefalu,William T. Cefalu,Eric Ravussin,Courtney M. Peterson,Courtney M. Peterson +7 more
TL;DR: It is demonstrated for the first time in humans that eTRF improves some aspects of cardiometabolic health and that IF's effects are not solely due to weight loss.
Journal ArticleDOI
Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
Robert E. Steinert,Christine Feinle-Bisset,Lori Asarian,Michael Horowitz,Christoph Beglinger,Nori Geary +5 more
TL;DR: Gastric emptying, the detection of specific digestive products by small intestinal enteroendocrine cells, and synergistic interactions among different GI loci all contribute to the secretion of ghrelin, CCK, GLP-1, and PYY(3-36).
Journal ArticleDOI
Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders.
S Steven,Kieren G. Hollingsworth,Ahmad Al-Mrabeh,Leah Avery,Benjamin S. Aribisala,Muriel J. Caslake,Roy Taylor +6 more
TL;DR: A robust and sustainable weight loss program achieved continuing remission of diabetes for at least 6 months in the 40% who responded to a VLCD by achieving fasting plasma glucose of <7 mmol/L, suggesting T2DM is a potentially reversible condition.
Journal ArticleDOI
Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery
TL;DR: Embracing this approach through the application of detailed phenotyping, genomics, metabolomics, and gut microbiome studies will enhance the understanding of metabolic regulation and help identify novel therapeutic targets.
References
More filters
Journal ArticleDOI
Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
TL;DR: The correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Journal ArticleDOI
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
TL;DR: A prospective, controlled Swedish Obese Subjects Study involved obese subjects who underwent gastric surgery and contemporaneously matched, conventionally treated obese control subjects, which reported follow-up data for subjects who had been enrolled for at least 2 years or 10 years before the analysis.
Journal ArticleDOI
Pathogenesis of NIDDM: A balanced overview
TL;DR: Information concerning the loss of first-phase insulin secretion, altered pulsatility of insulin release, and enhanced proinsulin-insulin secretory ratio is discussed as it pertains to altered β-cell function in NIDDM.
Journal ArticleDOI
Quantitative estimation of insulin sensitivity.
TL;DR: From a single glucose injection it is possible to obtain a quantitative index of insulin sensitivity that may have clinical applicability, and this index was defined as the ratio of two parameters of the chosen model and could be estimated with good reproducibility from the 300 mg/kg injection experiments.
Journal ArticleDOI
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Philip R. Schauer,Sangeeta R. Kashyap,Kathy Wolski,Stacy A. Brethauer,John P. Kirwan,Claire E. Pothier,Susan Thomas,Beth Abood,Steven E. Nissen,Deepak L. Bhatt,Deepak L. Bhatt +10 more
TL;DR: In obese patients with uncontrolled type 2 diabetes, 12 months of medical therapy plus bariatric surgery achieved glycemic control in significantly more patients than medical therapy alone.